SANGAMO THERAPEUTICS SHARES UP 9.3% PREMARKET AFTER CO RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR ITS EXPERIMENTAL TREATMENT FOR CHRONIC NERVE PAIN

Reuters · 3d ago

Please log in to view news